Tuesday, april 27 anatomy - Experimental Biology

Pathology
Tuesday
Pathology
950. BioBanking
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 11:30 a m-1:30 p m
A323 950.1 Human biospecimens collection in the era
of personalized medicine: challenges and perspectives. O.
Potapova. Cureline Inc., Burlingame, CA.
A324 950.2 Idiopathic pulmonary hypertension human
tissue biobank. W.E. Grizzle, K.C. Sexton, R.M. Tuder, V.V.
McLaughlin and S.B. Parker. Univ. of Alabama at Birmingham,
Univ. of Colorado Denver, Aurora and Univ. of Michigan.
951. Hemostasis
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 11:30 a m-1:30 p m
A325 951.1 Identification of a conformational epitope
induced when plasminogen binds to fibrin. K-H. Kim, N. Baik,
R.J. Parmer and L.A. Miles. The Scripps Res. Inst. and UCSD
and VA San Diego Healthcare Syst.
A326 951.2 von Willebrand factor and vWF propeptide
are upregulated in heparin-induced thrombocytopenia. J.M.
Walenga, D. Hoppensteadt, R. Davis, W. Jeske, V. Escalante,
B. Conway and J. Fareed. Loyola Univ. Med. Ctr. and GTI
Diagnostics, Waukesha, WI.
A327 951.3 The role of V Leiden, prothrombin G20210A and
C677T MTHFR mutations as risk factors for venous thrombosis
and recurrent pregnancy loss. A. Al Thani, R. Badii, M. Al-
Jaber, N. Almarii and S. Fahad. Qatar Univ. and Hamad Med.
Corp., Qatar.
A328 951.4 Biochip array analysis of various mediators
of inflammation in disseminated intravascular coagulation. S.
Rahman, D. Hoppensteadt, J. Cunanan, R. Davis, N. Sadeghi
and J. Fareed. Loyola Univ. Med. Ctr.
A329 951.5 Comparative studies on the USP reference
standard over-sulfated chondroitin sulfate and two semisynthetic
over-sulfated chondroitin sulfate preparations. N.
Sadeghi, D. Hoppensteadt, O. Iqbal, W. Jeske, J.M. Walenga
and J. Fareed. Loyola Univ. Med. Ctr.
A330 951.6 Differential immunogenic responses of branded
and generic versions of low molecular weight heparins. E.
Ramaciotti, M. Gomez, J.M. Walenga, D. Hoppensteadt, G.
Rao, H. Nader, W. Jeske and J. Fareed. Univ. of Michigan,
Loyola Univ. Med. Ctr., Lillehei Heart Inst., Minneapolis and
Fed. Univ. of São Paulo.
A331 951.7 Comparative studies on branded dalteparin
with two generic versions: hepagumin and fluzepamin. N.
Sadeghi, D. Hoppensteadt, O. Iqbal, W. Jeske, J.M. Walenga
and J. Fareed. Loyola Univ. Med. Ctr.
A332 951.8 Potency adjustment of unfractionated heparins
to harmonize the USP and WHO standardization: impact
on anticoagulant practice in the U.S. D. Hoppensteadt, N.
Sadeghi, O. Iqbal, R. Wahi, B. Lewis and J. Fareed. Loyola
Univ. Med. Ctr.
A333 951.9 Comparative studies on six unfractionated
heparin batches from China. N. Sadeghi, D. Hoppensteadt,
O. Iqbal, W. Jeske, J.M. Walenga and J. Fareed. Loyola Univ.
Med. Ctr.
A334 951.10 Different sources of over-sulfated chondroitin
sulfate may produce differential interactions with heparins. A.
Gray, D. Hoppensteadt, E. Litinas and J. Fareed. Loyola
Univ. Med. Ctr.
A335 951.11 Cross-reactivity of rabbit anti-bovine thrombin
IgGs with a human plasma-derived thrombin preparation
(Evithrom TM ). H. Zhu, D. Hoppensteadt, J. Cunanan and J.
Fareed. Loyola Univ. Med. Ctr.
A336 951.12 Increased microparticle procoagulant activity
in mice lacking alpha(1,3)-fucosyltransferase-IV and –VII. H.
Wang, M. Morales-Levy and J.W. Homeister. Univ. of North
Carolina at Chapel Hill.
A337 951.13 Elevated levels of circulating microparticles
in disseminated intravascular coagulation and their impact
on the inflammatory process. S. Rahman, M. Cichon, D.
Hoppensteadt, J. Cunanan, W. Jeske and J. Fareed. Loyola
Univ. Med. Ctr.
A338 951.14 Effect of tamoxifen and raloxifene on platelet
activation markers. Y. Dobrydneva and S.R. Vishneski.
Eastern Virginia Med. Sch.
A339 951.15 MBL-associated serine protease 1 is
necessary for thrombin substrate cleavage in vitro. L.R. La
Bonte, V. Pavlov, M. Takahashi, T. Fujita, K. Takahashi and
G.L. Stahl. Harvard Med. Sch., Fukushima Med. Univ., Japan
and Massachusetts Gen. Hosp.
952. Mucosal Barriers and Host-Pathogen
Defense
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 11:30 a m-1:30 p m
A340 952.1 Hepatocyte growth factor activator inhibitor
type 1 is required for the integrity of intestinal epithelium. M.
Kawaguchi, T. Fukushima, N. Takeda, S. Hoshiko, K. Yorita,
K. Kohama, H. Orikawa, T. Baba and H. Kataoka. Univ. of
Miyazaki and Univ. of Kumamoto, Japan.
A341 952.2 Role of periostin in epithelial injury. T.A. Reaves,
D.P. Lebel and J. Suber. Med. Univ. of South Carolina.
A342 952.3 Effects of claudin overexpression in carcinoma
cell lines. V.E. Zavala-Zendejas, A.C. Torres-Martínez, B.
Salas-Morales and E.P. Rendon-Huerta. UNAM, Mexico
City.
A343 952.4 Yin and yang: CCL2 and IL-10 in otitis mediainduced
inner ear inflammation. S.K. Moon, J-I. Woo, H. Pan,
X. Li and D.J. Lim. House Ear Inst., Los Angeles and Univ. of
Southern California.
A344 952.5 Galectin-3 mediates chronic airway allergic
inflammation and airway remodeling. X.N. Ge, N.S. Bahaie,
B.N. Kang, R.M. Hosseinkhani, S.G. Ha, E.M. Frenzel, F-T.
Liu, S.P. Rao and P. Sriramarao. Univ. of Minnesota, St. Paul
and Univ. of California Davis, Sacramento.
288